Geert R D'Haens

Summary

Affiliation: Katholieke Universiteit Leuven
Country: Belgium

Publications

  1. ncbi request reprint Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
    G D'Haens
    Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium
    Gastroenterology 120:1323-9. 2001
  2. ncbi request reprint Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
    G D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Gastroenterology 116:1029-34. 1999
  3. ncbi request reprint Infliximab (Remicade), a new biological treatment for Crohn's disease
    G R D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Ital J Gastroenterol Hepatol 31:519-20. 1999
  4. ncbi request reprint Anti-TNF therapy for Crohn's disease
    Geert D'Haens
    Department of Gastroenterology at the University Hospital Gasthuisberg, Leuven, Belgium
    Curr Pharm Des 9:289-94. 2003
  5. ncbi request reprint Infliximab as disease-modifying therapy
    Geert R D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Eur J Gastroenterol Hepatol 15:233-7. 2003
  6. doi request reprint Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
    Marc Ferrante
    Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium Electronic address
    Gastroenterology 145:978-986.e5. 2013
  7. ncbi request reprint Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial
    Geert R D'Haens
    Department of Gastroenterology, Leuven University Hospitals, Leuven, Belgium
    Gastroenterology 135:1123-9. 2008

Detail Information

Publications7

  1. ncbi request reprint Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
    G D'Haens
    Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium
    Gastroenterology 120:1323-9. 2001
    ..We investigated the effects of intravenous (IV) cyclosporine as single IV therapy (without glucocorticosteroids) for severe UC and compared these with the response to glucocorticosteroids...
  2. ncbi request reprint Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
    G D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Gastroenterology 116:1029-34. 1999
    ..Tumor necrosis factor (TNF) is a pivotal cytokine in intestinal inflammation. Controlled trials using a chimeric anti-TNF antibody (infliximab) have shown its efficacy in refractory Crohn's disease...
  3. ncbi request reprint Infliximab (Remicade), a new biological treatment for Crohn's disease
    G R D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Ital J Gastroenterol Hepatol 31:519-20. 1999
    ..In conclusion, infliximab appears to offer a promising novel therapeutic agent for refractory and fistulizing Crohn's disease. Long-term risks and benefits remain to be determined...
  4. ncbi request reprint Anti-TNF therapy for Crohn's disease
    Geert D'Haens
    Department of Gastroenterology at the University Hospital Gasthuisberg, Leuven, Belgium
    Curr Pharm Des 9:289-94. 2003
    ..Expected and unexpected safety toxicity data should caution clinicians to a certain extent against too liberal use of these agents interfering with very basic physiological events...
  5. ncbi request reprint Infliximab as disease-modifying therapy
    Geert R D'Haens
    Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Eur J Gastroenterol Hepatol 15:233-7. 2003
    ..Appropriate indications for using infliximab and growing experience with safety aspects have made this treatment a highly valuable tool in the management of Crohn's disease...
  6. doi request reprint Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
    Marc Ferrante
    Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium Electronic address
    Gastroenterology 145:978-986.e5. 2013
    ....
  7. ncbi request reprint Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial
    Geert R D'Haens
    Department of Gastroenterology, Leuven University Hospitals, Leuven, Belgium
    Gastroenterology 135:1123-9. 2008
    ..More than 80% of Crohn's disease (CD) patients undergoing resection suffer recurrence of their disease. Therapy with aminosalicylates, antimetabolites, or antibiotics leads to a modest reduction in the incidence of recurrence...